{"id":15039,"date":"2025-01-28T11:19:04","date_gmt":"2025-01-28T11:19:04","guid":{"rendered":"https:\/\/genekor.com\/2025\/01\/28\/tumor-profiling-tests-to-guide-adjuvant-chemotherapy-decision-in-early-breast-cancer\/"},"modified":"2025-02-12T12:45:15","modified_gmt":"2025-02-12T12:45:15","slug":"tumor-profiling-tests-to-guide-adjuvant-chemotherapy-decision-in-early-breast-cancer","status":"publish","type":"post","link":"https:\/\/genekor.com\/lv\/2025\/01\/28\/tumor-profiling-tests-to-guide-adjuvant-chemotherapy-decision-in-early-breast-cancer\/","title":{"rendered":"Audz\u0113ja profil\u0113\u0161anas testi lem\u0161anai par adjuvantu \u0137\u012bmijterapiju agr\u012bnas stadijas kr\u016bts v\u0113\u017ea \u0101rst\u0113\u0161anai"},"content":{"rendered":"\n<p><\/p>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-nice-diagnostikas-vadlinijas-efektivitates-un-lietderibas-vertesana\"><strong><strong><em>NICE<\/em>\u00a0diagnostikas vadl\u012bnijas: efektivit\u0101tes un lietder\u012bbas v\u0113rt\u0113\u0161ana<\/strong><\/strong><\/h3>\n\n\n\n<p><strong><br><\/strong><em>NICE<\/em> (Nacion\u0101l\u0101 vesel\u012bbas aizsardz\u012bbas un kl\u012bnisk\u0101s izcil\u012bbas instit\u016bta) diagnostikas vadl\u012bnij\u0101s\u00a0DG58 sniegti <strong>ar datiem pamatoti ieteikumi par terapeitisko l\u0113mumu pie\u0146em\u0161anu<\/strong> un pre\u010du un pakalpojumu <strong>efektivit\u0101tes un izmaksu lietder\u012bbas<\/strong> v\u0113rt\u0113\u0161anu Anglijas un Velsas vesel\u012bbas apr\u016bpes sist\u0113m\u0101.<\/p>\n\n\n\n<p><\/p>\n\n\n\n<p><\/p>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-vairakgenu-testu-mga-izmantosana-audzeju-profilesana\"><strong><strong>Vair\u0101kg\u0113nu testu\u00a0(<em>MGA<\/em>) izmanto\u0161ana audz\u0113ju profil\u0113\u0161an\u0101<\/strong><\/strong><\/h3>\n\n\n\n<p>Audz\u0113ja profil\u0113\u0161ana ar vair\u0101kg\u0113nu testiem ir izmantojama, lai pie\u0146emtu l\u0113mumus par adjuvantu \u0137\u012bmijterapiju, identific\u0113jot pacientus, kuriem:<\/p>\n\n\n\n<p>\u2022&nbsp;<strong>adjuvanta \u0137\u012bmijterapija var nepal\u012bdz\u0113t<\/strong>, un t\u0101 <strong>izvair\u012bties no nevajadz\u012bgas \u0101rst\u0113\u0161anas<\/strong>;<strong><\/strong><\/p>\n\n\n\n<p>\u2022&nbsp;<strong>faktiski pal\u012bdz\u0113tu \u0137\u012bmijterapija,<\/strong> lai gan <strong>kl\u012bnisku faktoru d\u0113\u013c<\/strong> vi\u0146iem ir <strong>mazs<\/strong> slim\u012bbas recid\u012bva <strong>risks<\/strong>.<\/p>\n\n\n\n<figure class=\"wp-block-image size-full\"><img loading=\"lazy\" decoding=\"async\" width=\"976\" height=\"394\" src=\"https:\/\/genekor.com\/wp-content\/uploads\/2025\/01\/image.png\" alt=\"\" class=\"wp-image-14915\" srcset=\"https:\/\/genekor.com\/wp-content\/uploads\/2025\/01\/image.png 976w, https:\/\/genekor.com\/wp-content\/uploads\/2025\/01\/image-300x121.png 300w, https:\/\/genekor.com\/wp-content\/uploads\/2025\/01\/image-768x310.png 768w\" sizes=\"auto, (max-width: 976px) 100vw, 976px\" \/><\/figure>\n\n\n\n<p><\/p>\n\n\n\n<p>\u0160is <em>NICE<\/em>\u00a0diagnostikas vadl\u012bniju \u201cAudz\u0113ja profil\u0113\u0161anas testi lem\u0161anai par adjuvantu \u0137\u012bmijterapiju agr\u012bnas stadijas kr\u016bts v\u0113\u017ea \u0101rst\u0113\u0161anai\u201d (<em>Tumour profiling tests to guide adjuvant chemotherapy decisions in early breast cancer<\/em>; DG58) kopsavilkums ir rekl\u0101mas materi\u0101ls. <em>NICE<\/em> speci\u0101listi ir p\u0101rbaud\u012bju\u0161i \u0161\u012bs informat\u012bv\u0101s lapas satura precizit\u0101ti tie\u0161i saist\u012bb\u0101 ar <em>NICE<\/em>\u00a0vadl\u012bnij\u0101m. <em>NICE<\/em>\u00a0ir neatkar\u012bgs no jebkura uz\u0146\u0113muma vai reklam\u0113jam\u0101s preces.<\/p>\n\n\n\n<p><\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-vairakgenu-testu-mga-ekonomiska-vertiba\"><strong>Vair\u0101kg\u0113nu testu\u00a0(<em>MGA<\/em>) ekonomisk\u0101 v\u0113rt\u012bba<\/strong><\/h2>\n\n\n\n<p>Ekonomikas model\u0113\u0161anas rezult\u0101ti liecina, ka sal\u012bdzin\u0101jum\u0101 ar sievie\u0161u standartapr\u016bpi p\u0113cmenopauzes period\u0101 <strong>Oncotype DX<\/strong><strong><sup>\u00d2<\/sup><\/strong>, EndoPredict\u00ae un Prosigna\u00ae izmanto\u0161ana no izmaksu viedok\u013ca ir lietder\u012bga. Sal\u012bdzin\u0101jum\u0101 ar audz\u0113ja profil\u0113\u0161anas testu neizmanto\u0161anu visu triju testu izmanto\u0161anas <strong>papildizmaksu lietder\u012bbas koeficients (<em>ICER<\/em>)<\/strong>&nbsp;bija <strong>&lt;&nbsp;20&nbsp;000&nbsp;sterli\u0146u m\u0101rci\u0146u par vienu<\/strong><strong> ieg\u016btu<\/strong> <strong>kvalit\u0101tes kori\u0123\u0113tu dz\u012bves gadu (<em>QALY<\/em>)<\/strong>.<\/p>\n\n\n\n<p>MammaPrint\u00ae kl\u012bnisk\u0101 efektivit\u0101te var b\u016bt maz\u0101ka un t\u0101 izmanto\u0161anas izmaksas \u2013 liel\u0101kas par standartapr\u016bpes izmaks\u0101m.<br><\/p>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-oncotype-dx-izmaksu-lietderiba\"><strong>Oncotype\u00a0DX\u00ae izmaksu lietder\u012bba<\/strong><\/h3>\n\n\n\n<p>3.18.<\/p>\n\n\n\n<p>Komisija ir secin\u0101jusi, ka <strong>Oncotype&nbsp;DX\u00ae <\/strong>izmanto\u0161ana <strong>no izmaksu viedok\u013ca var b\u016bt lietder\u012bgs<\/strong> NVD&nbsp;resursu izlieto\u0161anas veids, kad nepiecie\u0161ama pal\u012bdz\u012bba, <strong>lai pie\u0146emtu l\u0113mumu par adjuvantas \u0137\u012bmijterapijas noz\u012bm\u0113\u0161anu<\/strong> sieviet\u0113m p\u0113cmenopauzes period\u0101.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-ietekme-uz-kimijterapijas-pakalpojumiem\"><strong>Ietekme uz \u0137\u012bmijterapijas pakalpojumiem<\/strong><\/h3>\n\n\n\n<p>3.21.<\/p>\n\n\n\n<p>Sal\u012bdzin\u0101jum\u0101 ar audz\u0113ju profil\u0113\u0161anas testu neizmanto\u0161anu EndoPredict\u00ae, <strong>Oncotype&nbsp;DX\u00ae <\/strong>un Prosigna\u00ae izmanto\u0161ana var b\u016bt lietder\u012bga no izmaksu viedok\u013ca.<\/p>\n\n\n\n<p>3.21.<\/p>\n\n\n\n<p>Pamatojoties uz \u0101r\u0113jo v\u0113rt\u0113t\u0101ju grupas (<em>EAG<\/em>) izveidotu ekonomikas modeli, tika prognoz\u0113ts, ka <strong>Oncotype&nbsp;DX\u00ae <\/strong>izmanto\u0161ana <strong>\u0137\u012bmijterapiju \u013cautu noz\u012bm\u0113t par 594&nbsp;sieviet\u0113m maz\u0101k no katr\u0101m 1000&nbsp;test\u0113taj\u0101m sieviet\u0113m<\/strong>, bet EndoPredict\u00ae vai Prosigna\u00ae izmanto\u0161ana \u0161\u0101du sievie\u0161u skaitu \u013cautu samazin\u0101t aptuveni par&nbsp;40.<\/p>\n\n\n\n<p><em>ICER<\/em>&nbsp;\u2013 <em>incremental cost-effectiveness ratio<\/em> (papildizmaksu lietder\u012bbas koeficients)<\/p>\n\n\n\n<p><em>QALY<\/em>&nbsp;\u2013 <em>quality adjusted life year<\/em> (kvalit\u0101tes kori\u0123\u0113tie dz\u012bves gadi)<\/p>\n\n\n\n<p><em>EAG<\/em>&nbsp;\u2013 &nbsp;<em>external assessment group<\/em> (\u0101r\u0113jo v\u0113rt\u0113t\u0101ju grupa)<\/p>\n\n\n\n<p><\/p>\n","protected":false},"excerpt":{"rendered":"<p>NICE\u00a0diagnostikas vadl\u012bnijas: efektivit\u0101tes un lietder\u012bbas v\u0113rt\u0113\u0161ana NICE (Nacion\u0101l\u0101 vesel\u012bbas aizsardz\u012bbas un kl\u012bnisk\u0101s izcil\u012bbas instit\u016bta) diagnostikas vadl\u012bnij\u0101s\u00a0DG58 sniegti ar datiem pamatoti ieteikumi par terapeitisko l\u0113mumu pie\u0146em\u0161anu un pre\u010du un pakalpojumu efektivit\u0101tes [&hellip;]<\/p>\n","protected":false},"author":5,"featured_media":15020,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[120],"tags":[],"class_list":["post-15039","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news-lv"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v24.0 (Yoast SEO v24.0) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Audz\u0113ja profil\u0113\u0161anas testi lem\u0161anai par adjuvantu \u0137\u012bmijterapiju agr\u012bnas stadijas kr\u016bts v\u0113\u017ea \u0101rst\u0113\u0161anai - Genekor<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/genekor.com\/lv\/2025\/01\/28\/tumor-profiling-tests-to-guide-adjuvant-chemotherapy-decision-in-early-breast-cancer\/\" \/>\n<meta property=\"og:locale\" content=\"lv_LV\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Audz\u0113ja profil\u0113\u0161anas testi lem\u0161anai par adjuvantu \u0137\u012bmijterapiju agr\u012bnas stadijas kr\u016bts v\u0113\u017ea \u0101rst\u0113\u0161anai\" \/>\n<meta property=\"og:description\" content=\"NICE\u00a0diagnostikas vadl\u012bnijas: efektivit\u0101tes un lietder\u012bbas v\u0113rt\u0113\u0161ana NICE (Nacion\u0101l\u0101 vesel\u012bbas aizsardz\u012bbas un kl\u012bnisk\u0101s izcil\u012bbas instit\u016bta) diagnostikas vadl\u012bnij\u0101s\u00a0DG58 sniegti ar datiem pamatoti ieteikumi par terapeitisko l\u0113mumu pie\u0146em\u0161anu un pre\u010du un pakalpojumu efektivit\u0101tes [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/genekor.com\/lv\/2025\/01\/28\/tumor-profiling-tests-to-guide-adjuvant-chemotherapy-decision-in-early-breast-cancer\/\" \/>\n<meta property=\"og:site_name\" content=\"Genekor\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/genekorbiotechnology\/\" \/>\n<meta property=\"article:published_time\" content=\"2025-01-28T11:19:04+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-02-12T12:45:15+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/genekor.com\/wp-content\/uploads\/2025\/01\/logo-landscape-800x281-800x281-1.png\" \/>\n\t<meta property=\"og:image:width\" content=\"800\" \/>\n\t<meta property=\"og:image:height\" content=\"281\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Ioanna Potska\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Ioanna Potska\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/genekor.com\/lv\/2025\/01\/28\/tumor-profiling-tests-to-guide-adjuvant-chemotherapy-decision-in-early-breast-cancer\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/genekor.com\/lv\/2025\/01\/28\/tumor-profiling-tests-to-guide-adjuvant-chemotherapy-decision-in-early-breast-cancer\/\"},\"author\":{\"name\":\"Ioanna Potska\",\"@id\":\"https:\/\/genekor.com\/lv\/#\/schema\/person\/d6c43cd4b4be66582d408967392cbcbd\"},\"headline\":\"Audz\u0113ja profil\u0113\u0161anas testi lem\u0161anai par adjuvantu \u0137\u012bmijterapiju agr\u012bnas stadijas kr\u016bts v\u0113\u017ea \u0101rst\u0113\u0161anai\",\"datePublished\":\"2025-01-28T11:19:04+00:00\",\"dateModified\":\"2025-02-12T12:45:15+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/genekor.com\/lv\/2025\/01\/28\/tumor-profiling-tests-to-guide-adjuvant-chemotherapy-decision-in-early-breast-cancer\/\"},\"wordCount\":522,\"publisher\":{\"@id\":\"https:\/\/genekor.com\/lv\/#organization\"},\"image\":{\"@id\":\"https:\/\/genekor.com\/lv\/2025\/01\/28\/tumor-profiling-tests-to-guide-adjuvant-chemotherapy-decision-in-early-breast-cancer\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/genekor.com\/wp-content\/uploads\/2025\/01\/logo-landscape-800x281-800x281-1.png\",\"articleSection\":[\"news\"],\"inLanguage\":\"lv-LV\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/genekor.com\/lv\/2025\/01\/28\/tumor-profiling-tests-to-guide-adjuvant-chemotherapy-decision-in-early-breast-cancer\/\",\"url\":\"https:\/\/genekor.com\/lv\/2025\/01\/28\/tumor-profiling-tests-to-guide-adjuvant-chemotherapy-decision-in-early-breast-cancer\/\",\"name\":\"Audz\u0113ja profil\u0113\u0161anas testi lem\u0161anai par adjuvantu \u0137\u012bmijterapiju agr\u012bnas stadijas kr\u016bts v\u0113\u017ea \u0101rst\u0113\u0161anai - Genekor\",\"isPartOf\":{\"@id\":\"https:\/\/genekor.com\/lv\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/genekor.com\/lv\/2025\/01\/28\/tumor-profiling-tests-to-guide-adjuvant-chemotherapy-decision-in-early-breast-cancer\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/genekor.com\/lv\/2025\/01\/28\/tumor-profiling-tests-to-guide-adjuvant-chemotherapy-decision-in-early-breast-cancer\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/genekor.com\/wp-content\/uploads\/2025\/01\/logo-landscape-800x281-800x281-1.png\",\"datePublished\":\"2025-01-28T11:19:04+00:00\",\"dateModified\":\"2025-02-12T12:45:15+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/genekor.com\/lv\/2025\/01\/28\/tumor-profiling-tests-to-guide-adjuvant-chemotherapy-decision-in-early-breast-cancer\/#breadcrumb\"},\"inLanguage\":\"lv-LV\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/genekor.com\/lv\/2025\/01\/28\/tumor-profiling-tests-to-guide-adjuvant-chemotherapy-decision-in-early-breast-cancer\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"lv-LV\",\"@id\":\"https:\/\/genekor.com\/lv\/2025\/01\/28\/tumor-profiling-tests-to-guide-adjuvant-chemotherapy-decision-in-early-breast-cancer\/#primaryimage\",\"url\":\"https:\/\/genekor.com\/wp-content\/uploads\/2025\/01\/logo-landscape-800x281-800x281-1.png\",\"contentUrl\":\"https:\/\/genekor.com\/wp-content\/uploads\/2025\/01\/logo-landscape-800x281-800x281-1.png\",\"width\":800,\"height\":281},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/genekor.com\/lv\/2025\/01\/28\/tumor-profiling-tests-to-guide-adjuvant-chemotherapy-decision-in-early-breast-cancer\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/genekor.com\/lv\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Audz\u0113ja profil\u0113\u0161anas testi lem\u0161anai par adjuvantu \u0137\u012bmijterapiju agr\u012bnas stadijas kr\u016bts v\u0113\u017ea \u0101rst\u0113\u0161anai\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/genekor.com\/lv\/#website\",\"url\":\"https:\/\/genekor.com\/lv\/\",\"name\":\"Genekor\",\"description\":\"\u039c\u03bf\u03c1\u03b9\u03b1\u03ba\u03ae \u0393\u03b5\u03bd\u03b5\u03c4\u03b9\u03ba\u03ae\",\"publisher\":{\"@id\":\"https:\/\/genekor.com\/lv\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/genekor.com\/lv\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"lv-LV\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/genekor.com\/lv\/#organization\",\"name\":\"Genekor\",\"url\":\"https:\/\/genekor.com\/lv\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"lv-LV\",\"@id\":\"https:\/\/genekor.com\/lv\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/genekor.com\/wp-content\/uploads\/2021\/09\/logo-black.svg\",\"contentUrl\":\"https:\/\/genekor.com\/wp-content\/uploads\/2021\/09\/logo-black.svg\",\"width\":1,\"height\":1,\"caption\":\"Genekor\"},\"image\":{\"@id\":\"https:\/\/genekor.com\/lv\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/genekorbiotechnology\/\",\"https:\/\/gr.linkedin.com\/company\/genekor-sa\",\"https:\/\/www.youtube.com\/channel\/UCKC7sMFecVBY-OZAlRBHNzA\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/genekor.com\/lv\/#\/schema\/person\/d6c43cd4b4be66582d408967392cbcbd\",\"name\":\"Ioanna Potska\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"lv-LV\",\"@id\":\"https:\/\/genekor.com\/lv\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/ef44ac80c13d1335f0ea78257146bbf1?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/ef44ac80c13d1335f0ea78257146bbf1?s=96&d=mm&r=g\",\"caption\":\"Ioanna Potska\"}}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Audz\u0113ja profil\u0113\u0161anas testi lem\u0161anai par adjuvantu \u0137\u012bmijterapiju agr\u012bnas stadijas kr\u016bts v\u0113\u017ea \u0101rst\u0113\u0161anai - Genekor","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/genekor.com\/lv\/2025\/01\/28\/tumor-profiling-tests-to-guide-adjuvant-chemotherapy-decision-in-early-breast-cancer\/","og_locale":"lv_LV","og_type":"article","og_title":"Audz\u0113ja profil\u0113\u0161anas testi lem\u0161anai par adjuvantu \u0137\u012bmijterapiju agr\u012bnas stadijas kr\u016bts v\u0113\u017ea \u0101rst\u0113\u0161anai","og_description":"NICE\u00a0diagnostikas vadl\u012bnijas: efektivit\u0101tes un lietder\u012bbas v\u0113rt\u0113\u0161ana NICE (Nacion\u0101l\u0101 vesel\u012bbas aizsardz\u012bbas un kl\u012bnisk\u0101s izcil\u012bbas instit\u016bta) diagnostikas vadl\u012bnij\u0101s\u00a0DG58 sniegti ar datiem pamatoti ieteikumi par terapeitisko l\u0113mumu pie\u0146em\u0161anu un pre\u010du un pakalpojumu efektivit\u0101tes [&hellip;]","og_url":"https:\/\/genekor.com\/lv\/2025\/01\/28\/tumor-profiling-tests-to-guide-adjuvant-chemotherapy-decision-in-early-breast-cancer\/","og_site_name":"Genekor","article_publisher":"https:\/\/www.facebook.com\/genekorbiotechnology\/","article_published_time":"2025-01-28T11:19:04+00:00","article_modified_time":"2025-02-12T12:45:15+00:00","og_image":[{"width":800,"height":281,"url":"https:\/\/genekor.com\/wp-content\/uploads\/2025\/01\/logo-landscape-800x281-800x281-1.png","type":"image\/png"}],"author":"Ioanna Potska","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Ioanna Potska","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/genekor.com\/lv\/2025\/01\/28\/tumor-profiling-tests-to-guide-adjuvant-chemotherapy-decision-in-early-breast-cancer\/#article","isPartOf":{"@id":"https:\/\/genekor.com\/lv\/2025\/01\/28\/tumor-profiling-tests-to-guide-adjuvant-chemotherapy-decision-in-early-breast-cancer\/"},"author":{"name":"Ioanna Potska","@id":"https:\/\/genekor.com\/lv\/#\/schema\/person\/d6c43cd4b4be66582d408967392cbcbd"},"headline":"Audz\u0113ja profil\u0113\u0161anas testi lem\u0161anai par adjuvantu \u0137\u012bmijterapiju agr\u012bnas stadijas kr\u016bts v\u0113\u017ea \u0101rst\u0113\u0161anai","datePublished":"2025-01-28T11:19:04+00:00","dateModified":"2025-02-12T12:45:15+00:00","mainEntityOfPage":{"@id":"https:\/\/genekor.com\/lv\/2025\/01\/28\/tumor-profiling-tests-to-guide-adjuvant-chemotherapy-decision-in-early-breast-cancer\/"},"wordCount":522,"publisher":{"@id":"https:\/\/genekor.com\/lv\/#organization"},"image":{"@id":"https:\/\/genekor.com\/lv\/2025\/01\/28\/tumor-profiling-tests-to-guide-adjuvant-chemotherapy-decision-in-early-breast-cancer\/#primaryimage"},"thumbnailUrl":"https:\/\/genekor.com\/wp-content\/uploads\/2025\/01\/logo-landscape-800x281-800x281-1.png","articleSection":["news"],"inLanguage":"lv-LV"},{"@type":"WebPage","@id":"https:\/\/genekor.com\/lv\/2025\/01\/28\/tumor-profiling-tests-to-guide-adjuvant-chemotherapy-decision-in-early-breast-cancer\/","url":"https:\/\/genekor.com\/lv\/2025\/01\/28\/tumor-profiling-tests-to-guide-adjuvant-chemotherapy-decision-in-early-breast-cancer\/","name":"Audz\u0113ja profil\u0113\u0161anas testi lem\u0161anai par adjuvantu \u0137\u012bmijterapiju agr\u012bnas stadijas kr\u016bts v\u0113\u017ea \u0101rst\u0113\u0161anai - Genekor","isPartOf":{"@id":"https:\/\/genekor.com\/lv\/#website"},"primaryImageOfPage":{"@id":"https:\/\/genekor.com\/lv\/2025\/01\/28\/tumor-profiling-tests-to-guide-adjuvant-chemotherapy-decision-in-early-breast-cancer\/#primaryimage"},"image":{"@id":"https:\/\/genekor.com\/lv\/2025\/01\/28\/tumor-profiling-tests-to-guide-adjuvant-chemotherapy-decision-in-early-breast-cancer\/#primaryimage"},"thumbnailUrl":"https:\/\/genekor.com\/wp-content\/uploads\/2025\/01\/logo-landscape-800x281-800x281-1.png","datePublished":"2025-01-28T11:19:04+00:00","dateModified":"2025-02-12T12:45:15+00:00","breadcrumb":{"@id":"https:\/\/genekor.com\/lv\/2025\/01\/28\/tumor-profiling-tests-to-guide-adjuvant-chemotherapy-decision-in-early-breast-cancer\/#breadcrumb"},"inLanguage":"lv-LV","potentialAction":[{"@type":"ReadAction","target":["https:\/\/genekor.com\/lv\/2025\/01\/28\/tumor-profiling-tests-to-guide-adjuvant-chemotherapy-decision-in-early-breast-cancer\/"]}]},{"@type":"ImageObject","inLanguage":"lv-LV","@id":"https:\/\/genekor.com\/lv\/2025\/01\/28\/tumor-profiling-tests-to-guide-adjuvant-chemotherapy-decision-in-early-breast-cancer\/#primaryimage","url":"https:\/\/genekor.com\/wp-content\/uploads\/2025\/01\/logo-landscape-800x281-800x281-1.png","contentUrl":"https:\/\/genekor.com\/wp-content\/uploads\/2025\/01\/logo-landscape-800x281-800x281-1.png","width":800,"height":281},{"@type":"BreadcrumbList","@id":"https:\/\/genekor.com\/lv\/2025\/01\/28\/tumor-profiling-tests-to-guide-adjuvant-chemotherapy-decision-in-early-breast-cancer\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/genekor.com\/lv\/"},{"@type":"ListItem","position":2,"name":"Audz\u0113ja profil\u0113\u0161anas testi lem\u0161anai par adjuvantu \u0137\u012bmijterapiju agr\u012bnas stadijas kr\u016bts v\u0113\u017ea \u0101rst\u0113\u0161anai"}]},{"@type":"WebSite","@id":"https:\/\/genekor.com\/lv\/#website","url":"https:\/\/genekor.com\/lv\/","name":"Genekor","description":"\u039c\u03bf\u03c1\u03b9\u03b1\u03ba\u03ae \u0393\u03b5\u03bd\u03b5\u03c4\u03b9\u03ba\u03ae","publisher":{"@id":"https:\/\/genekor.com\/lv\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/genekor.com\/lv\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"lv-LV"},{"@type":"Organization","@id":"https:\/\/genekor.com\/lv\/#organization","name":"Genekor","url":"https:\/\/genekor.com\/lv\/","logo":{"@type":"ImageObject","inLanguage":"lv-LV","@id":"https:\/\/genekor.com\/lv\/#\/schema\/logo\/image\/","url":"https:\/\/genekor.com\/wp-content\/uploads\/2021\/09\/logo-black.svg","contentUrl":"https:\/\/genekor.com\/wp-content\/uploads\/2021\/09\/logo-black.svg","width":1,"height":1,"caption":"Genekor"},"image":{"@id":"https:\/\/genekor.com\/lv\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/genekorbiotechnology\/","https:\/\/gr.linkedin.com\/company\/genekor-sa","https:\/\/www.youtube.com\/channel\/UCKC7sMFecVBY-OZAlRBHNzA"]},{"@type":"Person","@id":"https:\/\/genekor.com\/lv\/#\/schema\/person\/d6c43cd4b4be66582d408967392cbcbd","name":"Ioanna Potska","image":{"@type":"ImageObject","inLanguage":"lv-LV","@id":"https:\/\/genekor.com\/lv\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/ef44ac80c13d1335f0ea78257146bbf1?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/ef44ac80c13d1335f0ea78257146bbf1?s=96&d=mm&r=g","caption":"Ioanna Potska"}}]}},"_links":{"self":[{"href":"https:\/\/genekor.com\/lv\/wp-json\/wp\/v2\/posts\/15039","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/genekor.com\/lv\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/genekor.com\/lv\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/genekor.com\/lv\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/genekor.com\/lv\/wp-json\/wp\/v2\/comments?post=15039"}],"version-history":[{"count":1,"href":"https:\/\/genekor.com\/lv\/wp-json\/wp\/v2\/posts\/15039\/revisions"}],"predecessor-version":[{"id":15041,"href":"https:\/\/genekor.com\/lv\/wp-json\/wp\/v2\/posts\/15039\/revisions\/15041"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/genekor.com\/lv\/wp-json\/wp\/v2\/media\/15020"}],"wp:attachment":[{"href":"https:\/\/genekor.com\/lv\/wp-json\/wp\/v2\/media?parent=15039"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/genekor.com\/lv\/wp-json\/wp\/v2\/categories?post=15039"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/genekor.com\/lv\/wp-json\/wp\/v2\/tags?post=15039"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}